Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Compass Therapeutics (CMPX) Non Operating Income (2023 - 2025)

Historic Non Operating Income for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to $1.6 million.

  • Compass Therapeutics' Non Operating Income fell 1137.66% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 2693.81%. This contributed to the annual value of $7.2 million for FY2024, which is 786.63% down from last year.
  • As of Q3 2025, Compass Therapeutics' Non Operating Income stood at $1.6 million, which was down 1137.66% from $1.2 million recorded in Q2 2025.
  • Compass Therapeutics' Non Operating Income's 5-year high stood at $2.1 million during Q2 2023, with a 5-year trough of $1.2 million in Q2 2025.
  • For the 3-year period, Compass Therapeutics' Non Operating Income averaged around $1.7 million, with its median value being $1.9 million (2023).
  • As far as peak fluctuations go, Compass Therapeutics' Non Operating Income surged by 581.64% in 2024, and later crashed by 3981.72% in 2025.
  • Over the past 3 years, Compass Therapeutics' Non Operating Income (Quarter) stood at $2.0 million in 2023, then dropped by 22.09% to $1.5 million in 2024, then grew by 1.1% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q3 2025, $1.2 million for Q2 2025, and $1.3 million during Q1 2025.